l3,10,13K7,8K4R2L9
General Information
DRACP ID DRACP00094
Peptide Name l3,10,13K7,8K4R2L9
Sequence KLlRLLkkLlRLlLK
Sequence Length 15
UniProt ID Not available
PubChem CID Not available
Origin Diastereomeric peptide
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
B16-F10 | Mouse melanoma | Carcinoma | LC50=2.5 µM | XTT assay | 24h | 1 |
D122 | Malignant tumors of the mouse pulmonary system | Carcinoma | LC50=4.5 µM | XTT assay | 24h | 1 |
Hemolytic Activity Human erythrocyte: Hemolysis% at 50 μm peptide LC50=0 µM
Normal (non-cancerous) Cytotoxicity NIH-3T3: LC50=40 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification l=D-Leucine; k=D-Lysine
Chiral Mix
Physicochemical Information
Formula C60H106N18O6
Absent amino acids ACDEFGHIMNPQSTVWY
Common amino acids L
Mass 142552
Pl 12.53
Basic residues 4
Acidic residues 0
Hydrophobic residues 6
Net charge 4
Boman Index -1142
Hydrophobicity 40
Aliphatic Index 156
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 12646578
Title Designed antimicrobial and antitumor peptides with high selectivity
Year 2003
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available